4D Molecular Therapeutics, Inc.
FDMT
$9.48
-$0.39-3.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.99% | 4.04% | -8.78% | -24.35% | -15.34% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 43.27% | -27.31% | -9.59% | 10.68% | 13.42% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 32.25% | 3.00% | -8.80% | -23.54% | -14.85% |
|
|
|||||
| Total Current Assets | 32.25% | 3.00% | -8.80% | -23.54% | -14.85% |
| Net Property, Plant & Equipment | -5.85% | -5.64% | -5.02% | -3.67% | -2.45% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.05% | -0.11% | 33.32% | 65.29% | 48.78% |
| Total Assets | 33.66% | -10.48% | -8.16% | -7.97% | -7.23% |
|
|
|||||
| Total Accounts Payable | 62.60% | -21.11% | 109.59% | -5.36% | 50.00% |
| Total Accrued Expenses | 11.10% | 26.05% | 18.43% | -14.13% | -11.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.81% | -0.45% | 0.74% | 0.75% | 10.72% |
| Total Finance Division Other Current Liabilities | 0.00% | -66.23% | 23.09% | 236.96% | 634.29% |
| Total Other Current Liabilities | 0.00% | -66.23% | 23.09% | 236.96% | 634.29% |
| Total Current Liabilities | 18.54% | 7.01% | 28.92% | -7.72% | -1.07% |
|
|
|||||
| Total Current Liabilities | 18.54% | 7.01% | 28.92% | -7.72% | -1.07% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.51% | -4.54% | -4.50% | -4.19% | -3.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -6.27% | 85.43% | -23.47% | -43.80% | -11.32% |
| Total Liabilities | 11.00% | 4.27% | 14.65% | -7.58% | -2.55% |
|
|
|||||
| Common Stock & APIC | 10.62% | 0.42% | 0.53% | 0.64% | 0.76% |
| Retained Earnings | 2.64% | -8.38% | -8.76% | -8.33% | -9.43% |
| Treasury Stock & Other | 8.35% | 99.11% | 1.51% | 44.98% | -78.78% |
| Total Common Equity | 37.04% | -12.33% | -10.40% | -8.01% | -7.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 37.04% | -12.33% | -10.40% | -8.01% | -7.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 37.04% | -12.33% | -10.40% | -8.01% | -7.66% |
|
|
|||||